U.S. market Closed. Opens in 1 day 11 hours 12 minutes

MNPR | Monopar Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses8.83M10.54M9.13M6.51M4.32M3.40M16.60M1.19M688.56K
Selling, General & Admin3.23M2.95M2.63M2.44M2.36M1.63M1.17M912.47K587.08K
Research & Development5.60M7.59M6.49M4.07M1.97M1.77M15.44M280.36K101.49K
Other Operating ExpensesN/AN/AN/AN/AN/AN/A14.50MN/AN/A
Operating Income-8.83M-10.54M-9.13M-6.51M-4.32M-3.40M-16.60M-1.19M-688.56K
Other Expenses / Income429.04K21.24K24.02K204.30K98.89K31.15K48.26K8.03K1.25K
Before Tax Income-8.40M-10.52M-9.10M-6.30M-4.22M-3.30M-16.55M-1.19M-687.31K
Income Tax ExpensesN/A-21.24K-24.02K-81.90K-98.89K-71.61K-2.10M800.00-688.56K
Net Income-8.40M-10.49M-9.08M-6.22M-4.13M-3.23M-16.55M-1.19M-687.31K
Interest ExpensesN/AN/AN/AN/AN/A103.22K48.26K7.23KN/A
Basic Shares Outstanding14.51M12.72M12.47M10.96M10.59M10.42M10.42M10.42M10.59M
Diluted Shares Outstanding14.51M12.72M12.47M10.96M10.59M10.42M10.42M10.42M10.59M
EBITDA429.04KN/AN/AN/AN/AN/A-16.55M8.03K1.25K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-8.40M-10.52M-9.10M-6.30M-4.22M-3.20M-18.61M-1.18M-1.38M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙